Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Elevated CAR has been associated with adverse outcomes in many conditions, including cancer, sepsis, COVID-19, and cardiovascular diseases. A higher C-reactive protein to albumin ratio (CAR) is ...

Chronic pain is a common complaint among those with COPD. Columnist Caroline Gainer shares the pain relief strategies that ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

The following is a summary of “Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...

Results did not differ by cardiovascular history. Conclusions ICS did not reduce MACE, except HF, likely by reducing misclassified COPD exacerbations. Whether inhaled corticosteroids (ICSs) should be ...

For people with the chronic obstructive pulmonary disease or COPD, secondhand smoke exposure can prompt an exacerbation of symptoms, which can lead to hospitalization. Traveling can put people with ...

Emerging research indicates that lipid accumulation dysfunction might significantly contribute to the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD). Nevertheless, the investigation into ...

CONCLUSIONS: Autopsy results suggest that common contributing causes of early death in patients hospitalized with severe COPD exacerbation are concomitant complications, as follows: cardiac ...